New HIV Vaccine Phase 1 Human Trial

A vaccine for human immunodeficiency virus (HIV) has proved successful in a Phase 1 clinical trail with no adverse effects in human patients.  The vaccine is the first genetically modified, whole-killed vaccine to be approved for testing in humans.

SAV001-H is the only HIV vaccine developed in Canada and one of the only few in the world.

Click on the title below to read the entire article:

New HIV Vaccine Proves Successful In Phase 1 Human Trial

Archives by Month:

Archives by Subject:

Archives by Year:

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015